Virginia / 2026 Regular Session

2026 Regular Session · Imported snapshot

HB831: Medication, drug, and vaccine ingredient labeling; Board of Pharmacy, et al., to study.

failed committee

<b>Board of Pharmacy; work group to study medication, drug, and vaccine ingredient labeling; report.</b> Directs the Board of Pharmacy to convene a work group to study medication, drug, and vaccine ingredient labeling. The bill directs the work group to review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (i) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (ii) accompanying informational inserts are readily available to consumers at a pharmacy upon request. The bill also directs the work group to study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The bill requires the work group to report its findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by December 1, 2026.

Official bill page · Source: Richmond Sunlight

Ask about HB831

Full bill text

Version HB831 · 2026-01-13 · Official source text

Full text

Changes in this version: added text deleted text

Be it enacted by the General Assembly of Virginia:

1. § 1. That the Board of Pharmacy shall convene a work group of relevant stakeholders to study medication, drug, and vaccine ingredient labeling. In completing its work, the work group shall (i) review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (a) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (b) accompanying informational inserts are readily available to consumers at a pharmacy upon request and (ii) study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The Board shall report the work group's findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by December 1, 2026.

Legislative actions

2026-01-23 · history

Subcommittee recommends laying on the table

2026-01-13 · history

Prefiled and ordered printed; Offered 01-14-2026 26103422D

2026-01-23 · history

House subcommittee offered

2026-01-22 · history

Assigned HRUL sub: Studies Subcommittee

2026-02-18 · history

Left in Committee Rules

2026-01-23 · history

Subcommittee recommends laying on the table (5-Y 0-N)

2026-01-13 · history

Referred to Committee on Rules

Raw source record
{
    "id": 84669,
    "url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/hb831\/",
    "tags": {
        "143236": "pharmacy",
        "143237": "labeling",
        "143238": "regulation",
        "143239": "health",
        "143240": "medication",
        "143241": "vaccines"
    },
    "text": [
        {
            "date": "2026-01-13",
            "number": "HB831",
            "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb831.pdf"
        }
    ],
    "type": "bill",
    "year": 2026,
    "video": null,
    "number": "hb831",
    "patron": "Kent, Hillary",
    "status": "failed committee",
    "chamber": "house",
    "changes": null,
    "outcome": "failed",
    "related": [
        {
            "id": 85485,
            "name": null,
            "year": 2026,
            "count": 3,
            "number": "sb486",
            "status": "failed committee",
            "catch_line": "Gluten disclaimer; required disclosures for dietary supplements and medication.",
            "date_introduced": "January 13, 2026"
        },
        {
            "id": 85717,
            "name": "Finance",
            "year": 2026,
            "count": 3,
            "number": "sb668",
            "status": "failed committee",
            "catch_line": "State pharmacy benefits manager; contractual provisions, report.",
            "date_introduced": "January 14, 2026"
        },
        {
            "id": 85718,
            "name": "Finance",
            "year": 2026,
            "count": 3,
            "number": "sb669",
            "status": "signed by governor",
            "catch_line": "Pharmacy benefits managers; requirements, application of law, report, delayed effective date.",
            "date_introduced": "January 14, 2026"
        },
        {
            "id": 83959,
            "name": null,
            "year": 2026,
            "count": 3,
            "number": "hb232",
            "status": "signed by governor",
            "catch_line": "Collaborative agreements; removes registered nurses from list of practitioners, etc.",
            "date_introduced": "January 08, 2026"
        },
        {
            "id": 84468,
            "name": "Appropriations",
            "year": 2026,
            "count": 3,
            "number": "hb631",
            "status": "failed committee",
            "catch_line": "State pharmacy benefits manager; contractual provisions, report.",
            "date_introduced": "January 13, 2026"
        }
    ],
    "summary": "<b>Board of Pharmacy; work group to study medication, drug, and vaccine ingredient labeling; report.<\/b> Directs the Board of Pharmacy to convene a work group to study medication, drug, and vaccine ingredient labeling. The bill directs the work group to review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (i) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (ii) accompanying informational inserts are readily available to consumers at a pharmacy upon request. The bill also directs the work group to study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The bill requires the work group to report its findings and recommendations to the Chairs of the House Committee on Health and Human Services and the Senate Committee on Education and Health by December 1, 2026.",
    "version": "HB831",
    "copatron": null,
    "committee": "Rules",
    "full_text": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=textbl><strong>1. <\/strong><ins>\u00a7 1. <\/ins><ins>That the Board of Pharmacy shall convene a work group of relevant stakeholders to study medication, drug, and vaccine ingredient labeling. In completing its work, the work group shall (i) review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (a) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (b) accompanying informational inserts are readily available to consumers at<\/ins><ins> a<\/ins><ins> pharmacy upon request and (ii) study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The Board shall report<\/ins><ins> the work group's<\/ins><ins> findings and recommendations to the Chairs <\/ins><ins>of the <\/ins><ins>House Committee on Health and Human Services and the Senate Committee on Education and Health by Dec<\/ins><ins>ember<\/ins><ins> 1, 202<\/ins><ins>6<\/ins><ins>.<\/ins><\/p>",
    "catch_line": "Medication, drug, and vaccine ingredient labeling; Board of Pharmacy, et al., to study.",
    "duplicates": null,
    "session_id": 32,
    "word_count": 208,
    "patron_party": "R",
    "patron_place": "Warsaw",
    "summary_hash": "08626a27084b4127ab6ac135b8c9f54d",
    "patron_prefix": "Del.",
    "patron_suffix": "(R-Warsaw)",
    "status_detail": "failed committee",
    "_rsun_versions": [
        {
            "id": "61cf88b3a1fca83fe291488815c10855562859d4c333d424af2db4dedc56fddb",
            "code": "HB831",
            "bill_id": 84669,
            "source_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb831.pdf",
            "source_date": "2026-01-13",
            "source_hash": "e1a6009ecc1ab160966a88375b82f24e7fd640e62a9e969253e8da924a93b44e",
            "source_html": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=textbl><strong>1. <\/strong><ins>\u00a7 1. <\/ins><ins>That the Board of Pharmacy shall convene a work group of relevant stakeholders to study medication, drug, and vaccine ingredient labeling. In completing its work, the work group shall (i) review all regulations related to medications, drugs, or vaccines sold or distributed in the Commonwealth to ensure that (a) all active and inactive ingredients contained in such medication, drug, or vaccine are clearly listed on the product packaging or accompanying informational insert and (b) accompanying informational inserts are readily available to consumers at<\/ins><ins> a<\/ins><ins> pharmacy upon request and (ii) study and make recommendations on the feasibility of requiring that any medication, drug, or vaccine sold or distributed in the Commonwealth that includes gluten as an active or inactive ingredient include a statement on the packaging or insert that such product contains gluten. The Board shall report<\/ins><ins> the work group's<\/ins><ins> findings and recommendations to the Chairs <\/ins><ins>of the <\/ins><ins>House Committee on Health and Human Services and the Senate Committee on Education and Health by Dec<\/ins><ins>ember<\/ins><ins> 1, 202<\/ins><ins>6<\/ins><ins>.<\/ins><\/p>",
            "source_metadata": {
                "bodyAssociation": "archive-reported-current-version",
                "archiveReference": {
                    "date": "2026-01-13",
                    "number": "HB831",
                    "pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/hb831.pdf"
                }
            }
        }
    ],
    "copatron_count": 0,
    "patron_address": [
        "P.O. Box 785",
        "Warsaw",
        "VA 22572"
    ],
    "patron_chamber": "house",
    "patron_started": 2024,
    "session_lis_id": 261,
    "status_history": [
        {
            "date": "02\/18\/2026",
            "status": "Left in Committee Rules",
            "date_raw": "2026-02-18",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "failed committee"
        },
        {
            "date": "01\/23\/2026",
            "status": "Subcommittee recommends laying on the table (5-Y 0-N)",
            "date_raw": "2026-01-23",
            "vote_count": null,
            "lis_vote_id": "292106",
            "translation": "failed subcommittee"
        },
        {
            "date": "01\/23\/2026",
            "status": "Subcommittee recommends laying on the table",
            "date_raw": "2026-01-23",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "failed subcommittee"
        },
        {
            "date": "01\/23\/2026",
            "status": "House subcommittee offered",
            "date_raw": "2026-01-23",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": null
        },
        {
            "date": "01\/22\/2026",
            "status": "Assigned HRUL sub: Studies Subcommittee",
            "date_raw": "2026-01-22",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in subcommittee"
        },
        {
            "date": "01\/13\/2026",
            "status": "Referred to Committee on Rules",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "in committee"
        },
        {
            "date": "01\/13\/2026",
            "status": "Prefiled and ordered printed; Offered 01-14-2026 26103422D",
            "date_raw": "2026-01-13",
            "vote_count": null,
            "lis_vote_id": null,
            "translation": "introduced"
        }
    ],
    "chief_patron_id": 512,
    "date_introduced": "2026-01-13",
    "patron_district": 67,
    "patron_shortname": "hpkent",
    "committee_chamber": "house",
    "status_detail_date": "02\/18\/2026",
    "committee_shortname": "rules",
    "patron_name_formatted": "Del. Hillary Pugh Kent (R-Warsaw)"
}